EpiPen: Price hike leaves Lubbock mom, nation weighing cost vs. health

The rising cost of the EpiPen isn’t new. It’s been increasing for years. A story by the Associated Press shows the price was about $94 nine years ago. It hit $608 in May.

 

“It shouldn’t cost that much,” said Charles Seifert, a professor of pharmacy practice and regional dean for Lubbock programs for the Texas Tech University Health Sciences Center School of Pharmacy. “The drug is generic.”

 

Read the full story here.

 

Related Stories

Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership

From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.

Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas

The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.

TTUHSC Names New Regional Dean for the School of Nursing

Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.

Recent Stories

Research

TTUHSC’s Hudson Set to Serve as President for Society of Clinical Research Associates

The Society of Clinical Research Associates (SOCRA) has elected Texas Tech University Health Sciences Center’s (TTUHSC) Catherine Hudson, Dr.P.H., as its president for 2025-2026.

Research

Clinical Research Institute a Source of Pride for Retiring Griswold

Upon his retirement, John Griswold, M.D., reflects on the Clinical Research Institute and what it has achieved.

Research

Abid Brings Hematology Expertise to TTUHSC Oncology Team

Muhammad Bilal Abid, M.D., has joined the TTUHSC School of Medicine oncology team as an associate professor of internal medicine and medical director of TTUHSC’s Blood and Marrow Transplantation & Cellular Therapy Program.